De novo inflammatory bowel disease and its mimics after organ transplantation

Inflammatory Bowel Diseases

Volumn 19, Issue 7, 2013, Pages 1518-1527

  Nepal, Sansrita ^a   Navaneethan, Udayakumar ^a   Bennett, Ana E ^a   Shen, Bo ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Bone marrow transplant; Inflammatory bowel disease; Liver transplant

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; FOSCARNET; GANCICLOVIR; MESALAZINE; METHYLPREDNISOLONE; METRONIDAZOLE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TACROLIMUS; TUMOR NECROSIS FACTOR INHIBITOR; VANCOMYCIN;

BACTERIAL INFECTION; BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; COLITIS; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ENTERITIS; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER TRANSPLANTATION; ORGAN TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTOZOAL INFECTION; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; VIRUS INFECTION;

COLITIS, ULCERATIVE; CROHN DISEASE; DIARRHEA; GRAFT VS HOST DISEASE; HUMANS; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTORS;

EID: 84879090620     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e3182813365     Document Type: Review

References (71)

1. Worns MA, Lohse AW, Neurath MF, et al. Five cases of de novo inflammatory bowel disease after orthotopic liver transplantation. Am J Gastroenterol. 2006;101:1931-1937.
2. Hampton DD, Poleski MH, Onken JE. Inflammatory bowel disease following solid organ transplantation. Clin Immunol. 2008;128:287-293.
3. Venkatesh PG, Navaneethan U, Shen B. Hepatobiliary disorders and complications of inflammatory bowel disease. J Dig Dis. 2011;12:245-256.
4. Sonwalkar SA, James RM, Ahmad T, et al. Fulminant Crohn's colitis after allogeneic stem cell transplantation. Gut. 2003;52:1518-1521.
5. Herrera AF, Soriano G, Bellizzi AM, et al. Cord colitis syndrome in cord-blood stem-cell transplantation. N Engl J Med. 2011;365:815-824.
6. Riley TR, Schoen RE, Lee RG, et al. A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease. Am J Gastroenterol. 1997;92:279-282.
7. Haagsma EB, Van Den Berg AP, Kleibeuker JH, et al. Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens. Aliment Pharmacol Ther. 2003;18:33-44.
8. Vu F, Maillard M, Pascual M, et al. De novo inflammatory bowel diseases after liver transplantation: description of four new cases and a review of the literature. Gastroenterol Clin Biol. 2006;30:1096-1101.
9. Jorgensen KK, Grzyb K, Lundin KE, et al. Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients. Inflamm Bowel Dis. 2012;18:536-545.
10. Shaked A, Colonna JO, Goldstein L, et al. The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation. Ann Surg. 1992;215:598-603.
11. Cuoco L, Tursi A, Cammarota G, et al. Onset of ulcerative colitis during immunosuppressive therapy for liver transplantation. Am J Gastroenterol. 1997;92:2134-2135.
12. Befeler AS, Lossoos TW, Schiano TD, et al. Clinical course and management of inflammatory bowel disease after liver transplantation. Transplantation. 1998;65:393-396.
13. Chalasani N, Smallwood G. Idiopathic ulcerative colitis in patients with primary sclerosing colitis undergoing orthotopic liver transplantation (OLT). Am J Gastroenterol. 1998;93:481-482.
14. Khan S, Lichtman SN, Reyes J, et al. Ulcerative colitis after liver transplant and immunosuppression. J Pediatr Gastroenterol Nutr. 1999;28:206-209.
15. Safadi R, Ilan Y, Galun E, et al. Primary Sclerosing cholangitis and liver transplantation. Transplant Proc. 1999;31:18-96.
16. Ramji A, Owen DA, Erb SR, et al. Post liver transplant Crohn's disease: graft tolerance but not self tolerance. Dig Dis Sci. 2002;47:522-527.
17. Wong NA, Bathgate AJ, Bellamy CO. Colorectal disease in liver allograft recipients-a clinicopathological study with follow-up. Eur J Gastroenterol Hepatol. 2002;14:231-236.
18. Papatheodoridis GV, Hamilton M, Mistry PK, et al. Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut. 1998;43:639-644.
19. Van De Vrie W, De Man RA, Van Buuren HR, et al. Inflammatory bowel disease and liver transplantation for primary sclerosing cholangitis. Eur J Gastroenterol Hepatol. 2003;15:657-663.
20. Papadakis KA, Matuk R, Abreu MT, et al. Crohn's ileitis after liver transplant from a liver related donor with Crohn's disease. Gut. 2004;53:1389-1390.
21. Ho GT, Seddon AJ, Therapondos G, et al. The clinical course of ulcerative colitis after orthotopic liver transplantation for primary sclerosing cholangitis; further appraisal of immunosuppression post transplantation. Eur J Gastroenterol Hepatol. 2005;17:1379-1385.
22. Maclean AR, Lilly L, Cohen Z, et al. Outcome of patients undergoing liver transplantation for primary sclerosing cholangitis. Dis Colon Rectum. 2003;46:1124-1128.
23. Verdonk RC, Dijkstra G, Haagsma EB, et al. Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease. Am J Transplant. 2006;6:1422-1429.
24. Cholangitas E, Papatheodoridis GV, Zappoli P, et al. Combined HLA-DR and-DQ disparity is associated with a stable course of ulcerative colitiss after liver transplantation for primary sclerosing cholangitis. Liver Transpl. 2007;13:552-557.
25. Halsey K, Reichelderfer M, Callicott RW, et al. Collagenous colitis presenting after othotopic liver transplantation for alpha-1-antitrypsin deficiency. Dig Dis Sci. 2007;52:217-219.
26. Barritt AS IV, Zacks SL, Rubinas TC, et al. Oral budesonide for the therapy of post-liver transplant de novo inflammatory bowel disease: a case series and systematic review of the literature. Inflamm Bowel Dis. 2008;14:1695-1700.
27. Jorgensen KK, Lindstrom L, Cvancarova M, et al. Clinical course of inflammatory bowel disease in liver transplanted PSC patients: a Nordic multicenter study. DDW. 2012:S-7-S-8.
28. Yen EF, Pardi DS. Review of the microscopic colitides. Curr Gastroenterol Rep. 2011;13:458-464.
29. Kaplan GG, Seminowich S, Williams J, et al. The risk of microscopic colitis in solid-organ transplantation patients: a population-based study. Transplantation. 2008;85:48-54.
30. Hashimoto MF, Sugawara YF, Tamura SF, et al. Clostridium difficile-associated diarrhea after living donor liver transplantation. World J Gastroenterol. 2007;19:2072-2076.
31. Iqbal N, Salzman D, Lazenby AJ, et al. Diagnosis of gastrointestinal graftversushost disease. Am J Gastroenterol. 2000;95:3034-3038.
32. Spiers AS. Ulcerative colitis after bone-marrow transplantation for acute leukemia. N Engl J Med. 1984;311:1259.
33. Koike K, Kohda K, Kuga T, et al. Ulcerative colitis after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Bone Marrow Transplant. 2001;28:619-621.
34. Cox GJ, Matsui SM, Lo RS, et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology. 1994;107:1398-1407.
35. Anderson CA, Boucher G, Lees CW, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet. 2011;43:919.
36. Foell D, Wittkowski H, Vogl T, et al. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol. 2007;81:28-37.
37. Vogl TF, Propper CF, Hartmann MF, et al. S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14. J Biol Chem. 1999;274:25291-25296.
38. Arns W. Noninfectious gastrointestinal (GI) complications of mycophenolic acid therapy: a consequence of local GI toxicity? Transplant Proc. 2007;39:88-93.
39. Fietze E, Prosch S, Reinke P, et al. Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor. Transplantation. 1994;58:675-680.
40. Rubin RH. Cytomegalovirus infection in the liver transplant recipient. Epidemiology, pathogenesis, and clinical management. Clin Liver Dis. 1997;1:439-452, x.
41. Verdonk RC, Haagsma EB, Kleibeuker JH, et al. Cytomegalovirus infection increases the risk for inflammatory bowel disease. Am J Pathol. 2010;176:3098.
42. Rahbar A, Bostrom L, Lagerstedt U, et al. Evidence of active cytomegalovirus infection and increased production of IL-6 in tissue specimens obtained from patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2003;9:154-161.
43. Poutanen SM, Simor AE. Clostridium difficile-associated diarrhea in adults. CMAJ. 2004;171:51-58.
44. Viazis N, Vlachogiannakos J, Georgiou O, et al. Course of inflammatory bowel disease in patients infected with human immunodeficiency virus. Inflamm Bowel Dis. 2010;16:507-511.
45. Markey KA, Burman AC, Banovic T, et al. Soluble lymphotoxin is an important effector molecule in GVHD and GVL. Blood. 2010;115:122-132.
46. Kreisel W, Potthoff K, Bertz H, et al. Complete remission of Crohn's disease after high-dose cyclophosphamide and autologous stem cell transplantation. Bone Marrow Transplant. 2003;32:337-340.
47. Oyama Y, Craig RM, Traynor AE, et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology. 2005;128:552-563.
48. Ditschkowski M, Einsele H, Schwerdtfeger R, et al. Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation. Transplantation. 2003;75:1745-1747.
49. Hommes DW, Duijvestein M, Zelinkova Z, et al. Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's disease. J Crohns Colitis. 2011;5:543-549.
50. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68:978-989.
51. Holler E, Rogler G, Herfarth H, et al. Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood. 2004;104:889-894.
52. Arango JI, Restrepo A, Schneider DL, et al. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant. 2006;37:517-521.
53. Kandiel A, Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol. 2006;101:2857-2865.
54. Navaneethan U, Venkatesh PG, Wang J. Cytomegalovirus ileitis in a patient after liver transplantation-differentiating from de novo IBD. J Crohns Colitis. 2011;5:354-359.
55. Wiggelinkhuizen M, Gerrits MA. Clostridium difficile-induced necrotizing enteritis. Ned Tijdschr Geneeskd. 2011;155:A2414.
56. Al-Absi AI, Cooke CR, Wall BM, et al. Patterns of injury in mycophenolate mofetil-related colitis. Transplant Proc. 2010;42:3591-3593.
57. Papadimitriou JC, Cangro CB, Lustberg A, et al. Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern. Int J Surg Pathol. 2003;11:295-302.
58. Parfitt JR, Jayakumar S, Driman DK. Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versushost disease-like changes. Am J Surg Pathol. 2008;32:1367-1372.
59. Chen Z, Scudiere JR, Montgomery E. Medication-induced upper gastrointestinal tract injury. J Clin Pathol. 2009;62:113-119.
60. Neumann S, Schoppmeyer K, Lange T, et al. Wireless capsule endoscopy for diagnosis of acute intestinal graft-versus-host disease. Gastrointest Endosc. 2007;65:403-409.
61. Akpek G, Chinratanalab W, Lee LA, et al. Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study. Biol Blood Marrow Transplant. 2003;9:46-51.
62. Warren S, Sommers SC. Pathology of regional ileitis and ulcerative colitis. J Am Med Assoc. 1954;154:189-193.
63. Ginsburg PM, Thuluvath PJ. Diarrhea in liver transplant recipients: etiology and management. Liver Transpl. 2005;11:881-890.
64. Lal S, Steinhart AH. Infliximab for ulcerative colitis following liver transplantation. Eur J Gastroenterol Hepatol. 2007;19:277-280.
65. Limaye AP. Ganciclovir-resistant cytomegalovirus in organ transplant recipients. Clin Infect Dis. 2002;35:866-872.
66. Limaye AP. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients. Semin Respir Infect. 2002;17:265-273.
67. Fica A, Cervera C, Perez N, et al. Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests. Transpl Infect Dis. 2007;9:203-210.
68. Budde K, Glander P, Diekmann F, et al. Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients. Transplant Proc. 2004;36:524S-527S.
69. Wolff DF, Gerbitz AF, Ayuk FF, et al. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. Biol Blood Marrow Transplant. 2010;12:1611-1628.
70. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204-217.
71. Roy J, Snover D, Weisdorf S, et al. Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft-versus-host disease. Transplantation. 1991;51:642-646.